Clinical Trial Update: A Multiple Dose Opioid Challenge Study [Phase 2]

View source ↗

Summary

Phase 2 multiple-dose opioid challenge study completed for moderate to severe opioid use disorder; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Snippet

Sponsor: Braeburn Pharmaceuticals | Conditions: Moderate or Severe Opioid Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2019-11-14